FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015954787> ?p ?o ?g. }

• W2015954787 endingPage "46124" @default.
• W2015954787 startingPage "46118" @default.
• W2015954787 abstract "Immune responses to parasitic helminth are usually characterized by quite mysterious phenomena: dominance of Th2-like immunity and antigen-nonspecific IgE secretion. We previously purified a factor from Dirofilaria immitis that induces antigen-nonspecific IgE in rats and named it DiAg. In the presence of IL-4, DiAg induces mouse B cells to secrete IgE, which is antigen-nonspecific polyclonal antibody. We investigated the biochemical characteristics of DiAg as a factor of inducing IgE in this study. Recombinant DiAg (rDiAg) with interleukin (IL)-4 induced IgE synthesis in highly purified human normal B cells in vitrocell culture systems. The addition of recombinant human soluble CD40 IgG fusion protein (rsCD40-Ig) inhibited induction of IgE synthesis by rDiAg with IL-4. Monocyte cells were stimulated with rDiAg and recombinant human soluble CD40L (rsCD40L); IL-12 and TNF-α were induced. The addition of rsCD40-Ig to THP-1 cells activated with rDiAg and rsCD40L inhibited the production of IL-12. rDiAg bound to the monocyte cell membrane fraction and recombinant human soluble CD40; this binding of rDiAg was competitively inhibited by addition of rsCD40L. Moreover, in CD40-deficient mice, IgE production and MLN-B cell proliferation by rDiAg were completely absent. Based on these results, we concluded that DiAg is an agonist of CD40. Immune responses to parasitic helminth are usually characterized by quite mysterious phenomena: dominance of Th2-like immunity and antigen-nonspecific IgE secretion. We previously purified a factor from Dirofilaria immitis that induces antigen-nonspecific IgE in rats and named it DiAg. In the presence of IL-4, DiAg induces mouse B cells to secrete IgE, which is antigen-nonspecific polyclonal antibody. We investigated the biochemical characteristics of DiAg as a factor of inducing IgE in this study. Recombinant DiAg (rDiAg) with interleukin (IL)-4 induced IgE synthesis in highly purified human normal B cells in vitrocell culture systems. The addition of recombinant human soluble CD40 IgG fusion protein (rsCD40-Ig) inhibited induction of IgE synthesis by rDiAg with IL-4. Monocyte cells were stimulated with rDiAg and recombinant human soluble CD40L (rsCD40L); IL-12 and TNF-α were induced. The addition of rsCD40-Ig to THP-1 cells activated with rDiAg and rsCD40L inhibited the production of IL-12. rDiAg bound to the monocyte cell membrane fraction and recombinant human soluble CD40; this binding of rDiAg was competitively inhibited by addition of rsCD40L. Moreover, in CD40-deficient mice, IgE production and MLN-B cell proliferation by rDiAg were completely absent. Based on these results, we concluded that DiAg is an agonist of CD40. phosphate-buffered saline mesenteric lymph node enzyme-linked immunosorbent assay peripheral blood mononuclear cell lipopolysaccharide 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide tumor necrosis factor dendritic cell Parasitic helminth infections are characterized by mast cell hyperplasia, eosinophilia (1Wynn T.A. Mem. Inst. Oswaldo. Cruz. 1997; 92: 105-108Crossref PubMed Scopus (9) Google Scholar), and markedly elevated levels of circulating antigen nonspecific IgE (2Ishizaka T. Urban Jr., J.F. Takatsu K. Ishizaka K. J. Allergy Clin. Immunol. 1976; 58: 523-538Abstract Full Text PDF PubMed Scopus (26) Google Scholar), which responses were concerned to helminth protection (3Pritchard D.I. Parasite Immunol. 1993; 15: 5-9Crossref PubMed Scopus (84) Google Scholar, 4Else K.J. Finkelman F.D. Int. J. Parasitol. 1998; 28: 1145-1158Crossref PubMed Scopus (209) Google Scholar). Parasitic antigen-specific IgE is associated with elimination of parasites from infected hosts, while antigen-nonspecific polyclonal IgE may be involved in the survival of invading parasites (3Pritchard D.I. Parasite Immunol. 1993; 15: 5-9Crossref PubMed Scopus (84) Google Scholar, 5Jarrett E.E. Miller H.R.P. Prog. Allergy. 1982; 31: 178-233PubMed Google Scholar, 6Maizels R.M. Bundy D.A.P. Selkirk M.E. Smith D.F Anderson R.M. Nature. 1993; 365: 797-799Crossref PubMed Scopus (468) Google Scholar). We have previously reported that excretory-secretory component (native DiAg) isolated fromDirofilaria immitis induces both total IgE production in human spleen cells and CD23 expression on human splenic B cells in the presence of IL-4 (7Yamaoka K. Kolb J.P. Miyasaka N. Inuo G. Fujita K. Immunology. 1994; 81: 507-512PubMed Google Scholar). Lee et al. demonstrated thatAscaris suum pseudocoelomic body fluid contains a B cell mitogen (8Lee T.D.G. Xie C.Y. J. Allergy Clin. Immunol. 1995; 95: 1247-1254Abstract Full Text Full Text PDF Scopus (38) Google Scholar) and induces high levels of total circulating IgE (9Lee T.D.G. McGibbon A. Int. Arch. Allergy Immunol. 1993; 102: 185Crossref PubMed Scopus (24) Google Scholar). We previously purified a factor from D. immitisthat induces antigen-nonspecific IgE in mice and rats and named it DiAg (10Furuhasi Y. Imai S. Tezuka H. Fujita K. Int. Arch. Allergy Immunol. 2001; 125: 144-151Crossref PubMed Scopus (8) Google Scholar). DiAg was identical to one already identified as a polyradderprotein, or neutrophil chemotactic factor (DiNCF; GenBankTM accession number D88757) (11Horii Y. Fujita K. Owhashi M. J. Parasitol. 1986; 72: 315-320Crossref PubMed Scopus (10) Google Scholar). To further characterize DiAg, we produced its recombinant protein, rDiAg, inEscherichia coli and analyzed its characteristics in a number of studies. rDiAg induces transmission of a mitogenic signal to mouse B cells, which in turn induces secretion of IgE in the presence of IL-4. Immune responses to parasitic helminth are usually characterized by two quite mysterious phenomena: dominance of Th2-like immunity and antigen-nonspecific IgE secretion. DiAg might cause these unique phenomena in the case of filarial infection. A number of critical questions about the mechanisms of polyclonal IgE synthesis remain to be resolved. First, it is not clear which molecules play an essential role in DiAg-induced activation of B cells. Second, the mechanisms by which IL-4 induces IgE secretion in helminth infection are not clear, although it has been established that the process is dependent on activated Th2 cells. T cell-dependent antigen-specific IgE synthesis in B cells requires that the signal be delivered by interaction of the B cell surface antigen CD40 with its ligand (CD40L) (12Noel R.J. Roy M. Shepherd D.M. Stamenkovic I. Ledbetter J.A. Aruffo A. Proc. Natl. Acad. Sci. U. S. A. 1992; 89: 6550-6554Crossref PubMed Scopus (795) Google Scholar) expressed on activated T cells (13Armitage R.J. Fanslow W.C. Strockbine L. Sato T.A. Clifford K.N. Macduff B.M. Anderson D.M. Gimplet S.T. Davis-Smith T. Maliszewski C.R. Clark E.A. Smith C.A. Grabstein K.H. Cosman D. Spriggs M.K. Nature. 1992; 357: 80-82Crossref PubMed Scopus (988) Google Scholar) with IL-4 or IL-13. CD40 is a 50-kDa glycoprotein expressed on B cells (14Clark E.A. Tissue Antigens. 1990; 36: 33-36Crossref PubMed Scopus (74) Google Scholar), dendritic cells, epithelial cells (15Schriever F. Freedman A.S. Freeman G. Messner E. Lee G. Daley J. Nadler L.M. J. Exp. Med. 1989; 169: 2043-2058Crossref PubMed Scopus (190) Google Scholar, 16Galy A.H. Spits H. J. Immunol. 1992; 149: 775-782PubMed Google Scholar), and monocytes (17Alderson M.R. Armitage R.J. Tough T.W. Strockbine L. Fanslow W.C. Spriggs M.K. J. Exp. Med. 1993; 178: 669-674Crossref PubMed Scopus (540) Google Scholar). CD40L is directly bound to CD40 on B cells and induces mitogenicity in murine and human B cells (18Spriggs M.K. Armitage R.J. Strockbine L. Clifford K.N. Macduff B.M. Sato T.A. Maliszewski C.R. Fanslow W.C. J. Exp. Med. 1992; 176: 1543-1550Crossref PubMed Scopus (392) Google Scholar, 19Armitage R.J. Macduff B.M. Spriggs M.K. Fanslow W.C. J. Immunol. 1993; 150: 3671-3680PubMed Google Scholar); it can also induce secretion of all immunoglobulin isotypes in the presence of cytokines (20Maliszewski C.R. Grabstein K. Fanslow W.C. Armitage R.J. Spriggs M.K. Sato T.A. Eur. J. Immunol. 1993; 23: 1044-1049Crossref PubMed Scopus (114) Google Scholar). rDiAg has been previously shown to induce IgE secretion of splenic B cells from naive mice with IL-4 in vitro culture system in the absence of T cells. 1H. Tezuka, S. Imai, Y. Furuhashi, R. Muto, and K. Fujita, submitted for publication. It suggests that the engagement of antigen-specific T cell to B cells is not involved in induction of IgE by rDiAg. DiAg might induce the IgE class switching via the CD40 molecule with the IL-4. We therefore investigated the biochemical characteristics of DiAg as a CD40 agonist. CD40L has been shown to induce cytokine production in peripheral blood monocytes and T cells (22Armitage R.J. Tough T.W. Macduff B.M. Fanslow W.C. Spriggs M.K. Ramsdell F. Alderson M.R. Eur. J. Immunol. 1993; 23: 2326-2331Crossref PubMed Scopus (113) Google Scholar). It is known that human monocyte-like THP-1 cells produce proinflammatory cytokines by CD40L stimulation (23Yoshimoto T. Nagase H. Ishida T. Inoue J. Nariuchi H. Eur. J. Immunol. 1997; 27: 3461-3470Crossref PubMed Scopus (68) Google Scholar). We have previously shown that rDiAg induces IgE production in rats. However, actions of rDiAg on human cell lines remain to be elucidated. We report here that rDiAg have various biological activity to the human cell lines and B cell population. The V1 domain (a repeating unit) of DiAg gene was amplified by polymerase chain reaction (PCR) with primers (5′-primer, including NdeI restriction site: 5′-GCATATGAATGATCATAATTTAGAAAGC-3′, 3′-primer, including BamHI restriction site: 5′-CTAAAGGATCCTATCACCGCTTACGCCGTTCATTCATTG-3′) from pDi6 (24Owhashi M. Futaki S. Kitagawa K. Horii I. Maruyama H. Hayshi H. Nawa Y. Mol. Immunol. 1993; 30: 1315-1320Crossref PubMed Scopus (18) Google Scholar), gifts from Dr. Makoto Owhashi, Univ. of Tokusima, Tokusima, Japan), which code DiAg. Amplified DNA was digested with NdeI andBamHI and cloned into pET3a vectors for expression inE. coli HMS174 (DE3). All constructs were verified by DNA sequencing. The purification of rDiAg was performed as follows. Five g of cell paste was suspended in 30 ml of 50 mm HCl and 5 mm EDTA at 4 °C and then centrifuged at 12,000 ×g for 10 min. Recombinant DiAg in the supernatant was precipitated by 60–80% saturated ammonium sulfate and then applied on a Superdex 200 column. Contaminants of pyrogen from E. coliwere removed from concentrated rDiAg solution by immobilized polymixin B. The isolated rDiAg protein was lyophilized and stored at −20 °C until use. The extracellular domain of the human CD40 gene was amplified by PCR with primers (5′-primer: 5′-GCTCATATGCCAGAACCACCCACTGC-3′, antisense primer: 5′-GGAGCCAGGAAGATCGTCGGGAAA-3′) from cDNA (CLONTECH) of human leukocytes. Amplified DNA was digested with NdeI and BamHI and cloned into pET3a vectors for expression in E. coli HMS174 (DE3). All constructs were verified by DNA sequencing. The purification of rsCD40 was performed as follows. Five g of cell paste was suspended in 30 ml of lysis buffer (8 m urea, 100 mm Tris-HCl, pH 8.8) and sonicated by sonicator on ice. The lysate was centrifuged at 27,000 × g for 20 min. The supernatant was applied on a Mono-Q column (Amersham Pharmacia Biotech, 5 mm φ × 50 mm) preequilibrated with the same buffer. The active fraction was pooled and was precipitated by adding 80% saturated ammonium sulfate. The precipitate was suspended in PBS2 and then applied on a Superdex 75 (Amersham Pharmacia Biotech, 10 mm φ × 300 mm) column chromatography preequilibrated with PBS. Contaminants of pyrogen from E. coli were removed from concentrated rsCD40 solution by immobilized polymixin B. Construction procedure of rsCD40-Ig was performed as described by Hsu (25Hsu Y-M. Lucci J. Su L. Ehrenfels B. Garber E. Thomas D. J. Biol. Chem. 1997; 272: 911-915Abstract Full Text Full Text PDF PubMed Scopus (46) Google Scholar). Osmotic pumps (Alza) filled with rDiAg or ovalbumin in 100 μl of phosphate-buffered saline were subcutaneously infused in female 6-week-old mice (wild-type C57BL/6 or CD40-deficient B6.129P2-Tnfsf5tm1Kik; Jackson Laboratory stock number 002928). The pumping rate of an osmotic pump is 0.25 μl/h continuously, and the duration is 14 days. IgE concentrations of plasma were measured by the ELISA kits (Bethyle). Antigen-specific IgE were measured by ELISA. One microgram of rDiAg or ovalbumin in 100 μl was coated onto a 96-well plate (Maxisorb, Nunc) at 4 °C for 16 h. The wells were then washed with PBS and blocked with milk casein (BlockA, Yukijirushi) for 1 h at 37 °C. After washing with PBS, 100 μl of diluted serum (100–12800 folds dilution in PBS) was added and incubated for 1 h at 4 °C. After washing with PBS, bound antibody was detected by peroxidase-conjugated anti-mouse IgE (Nordic Immunological Laboratory) antibody. PBMCs were isolated from heparinized blood obtained from normal non-atopic donors by density-gradient centrifugation on Ficoll Hypaque (Amersham Pharmacia Biotech). Cells were then washed and resuspended in RPMI 1640 containing 10% heat-inactivated fetal calf serum (JRH Biosciences), 2 mm l-glutamine, 50 μg/ml streptomycin and 100 units/ml penicillin (complete medium). Purified B cell populations were isolated from PBMCs by positive sorting by magnetic cell sorting system (Miltenyi Biotec) with magnetic beads conjugated to CD19 according to the manufacturer's instructions. For IgE production, human B cells (1.5 × 106 cells/ml) were cultured in complete medium in the presence of IL-4 (500 units/ml) plus either rsCD40L (2 μg/ml) or rDiAg (10 μg/ml). After 14 days, supernatants were harvested and assessed for their IgE content. In certain experiments, rsCD40-Ig and rsTNFR-Ig were added to the cultures. Levels of human IgE in culture supernatants were measured using ELISA kit (Bethyl). Net IgE synthesis was calculated by subtracting the amount of IgE detected in the supernatants of cycloheximide-treated (100 μg/ml) cell cultures. The sensitivity of the assay was 3 ng/ml. THP-1 cells (2 × 106) were cultured in 24-well plates with 10 μg/ml of rDiAg, rsCD40L, and LPS in 1 ml of culture medium (RPMI 1640 supplemented with 10% fetal calf serum) with (for TNF-α induction) 2 mm hydroxyurea and 50 μg/ml silica powder or without (for IL-12 induction) and with or without 20 units/ml IL-10 at 37 °C for 24 h in a humidified atmosphere of 5% CO2. For IL-12 inhibition assays, various concentration (0.3–30 μg/ml) of rsCD40-Ig or rsTNFR-Ig was added to cell culture with 1 μg/ml of rDiAg, rsCD40L, and LPS. After 24 h, supernatants were recovered for determination of IL-12 and TNF-α concentrations. The IL-12 and TNF-α concentrations of supernatants were measured by the ELISA kits (IL-12, Endogen; TNF-α, R&D Systems). THP-1 or Ramos cells were cultured in 250 ml of culture medium (RPMI 1640 supplemented with 10% fetal calf serum) at 37 °C for 24 h in a humidified atmosphere of 5% CO2. The confluent cells (3 × 108) were homogenized in buffer (5 mm Tris-HCl, pH 7.4, 2 mm EDTA, 5 μg/ml subtilicin inhibitor, 5 μg/ml leupeptin, 10 μg/ml benzamidine) by a politron homogenizer at maximum speed on ice. The homogenate was centrifuged at 500 × g for 5 min at 4 °C. The supernatant was centrifuged at 48,000 × g for 30 min at 4 °C. The precipitate was suspended in buffer (75 mmTris-HCl, pH 7.4, 12.5 mm MgCl2, 2 mm EDTA, 5 μg/ml subtilicin inhibitor, 5 μg/ml leupeptin, 10 μg/ml benzamidine) and the aliquots were stored at −80 °C until use. rDiAg and rsCD40L were radiolabeled with Bolton-Hunter reagent (diiodinate 163 TBq/mmol, PerkinElmer Life Sciences). Radiolabeled rDiAg and rsCD40L were purified by gel filtration. Membrane aliquots (40 μg of proteins) were incubated for 1 h at 4 °C with or without a protecting ligand in 50 mm Tris-HCl, pH 7.5, 2 mm EDTA, 0.2% bovine serum albumin, and 1 μm phenylmethylsulfonyl fluoride. Preincubated membranes were incubated with ∼0.98–31.2 nm125I-rDiAg or 125I-rsCD40L with or without competitor for 15 h at 4 °C. After incubation, radioligand binding membranes were filtrated on Whatman GF/B filters by a cell harvester, and the filters were washed with phosphate buffer saline. The radioactivity of filters was then determined by a γ counter (Aloka). Serial dilutions of purified rDiAg, rsCD40L, and TNF-α were coated onto a 96-well plate (Maxisorb, Nunc) at 4 °C for 16 h. The wells were then washed with PBS and blocked with milk casein (BlockA, Yukijirushi) for 1 h at 37 °C. After washing with PBS, 100 μl of rsCD40-Ig or rsTNFR-Ig (2 μg/ml diluted in 0.1% bovine serum albumin in PBS) was added and was incubated for 1 h at 4 °C. After washing with PBS, bound antibody was detected by peroxidase-conjugated anti-IgG Fc antibody (Jackson). Cell preparation MLN-B cells were freshly prepared from small intestine of wild-type or CD40-deficient mice. Briefly, MLN cells were placed on 25-mm2 tissue culture flasks at 37 °C for 1 h to deplete adherent cell fractions contaminating macrophages (repeat three times). Nonadherent cell fraction was treated with rabbit anti-mouse Thy-1.2 antibody (diluted 1:20; Cedalane Laboratory) at 4 °C for 1 h and subsequently with low-tox rabbit complement (diluted 1:10; Cedalane Laboratory) at 37 °C for 1 h to deplete T cell fraction. Cell proliferation MLN-B cells (1 × 106cells/ml) were incubated with various doses of rDiAg or LPS for several hours in a total volume of 1 ml in 24-well flat-bottomed plates. The cell proliferation was measured by a modified colorimetric MTT reduction assay. Briefly, at 4 h before the end of the culture, the cells were resuspended with 1 ml of fresh serum-free medium, and 100 μl of MTT solution (5 mg/ml in PBS) were added to each well. After incubation for 4 h, 900 μl of acid-isopropanol (0.04 n HCl in isopropanol with 10% Me2SO) was added to each well and mixed well by pipetting. The mixture was allowed to stand for 30 min at room temperature. Two hundred ml of each medium was aliquoted into 96-well plates, and the dissolved MTT crystals were quantitated. The optical densities were measured at 570 nm, attest wavelength, and at 630 nm, a reference wavelength, using a microplate reader. Serum immunoglobulin levels of C57BL/6J mice are shown in Fig.1 a. A significant level of IgE production was induced in rDiAg-infused mice, with peak IgE production occurring on day 21, and the level decreased gradually until day 28. In contrast, antigen-specific IgE levels were not detected at anytime points measured (Fig. 1 b). Our results were in agreement with the previous report of marked elevation of polyclonal IgE levels in the early phase of Nippostrongylus brasiliensisinfections (5Jarrett E.E. Miller H.R.P. Prog. Allergy. 1982; 31: 178-233PubMed Google Scholar). The same phenomenon has also been observed in rats (10Furuhasi Y. Imai S. Tezuka H. Fujita K. Int. Arch. Allergy Immunol. 2001; 125: 144-151Crossref PubMed Scopus (8) Google Scholar). rsCD40L or rDiAg in the presence of IL-4 induced IgE synthesis in highly purified human normal B cells in vitro cell culture systems. To assess the role of CD40L in the induction of IgE synthesis by rDiAg in normal B cells, we examined the effect of blocking CD40L-CD40 interactions. For this purpose, we used a recombinant soluble CD40-IgG fusion protein (rsCD40-Ig), which has been shown previously to inhibit IL-4-driven CD40L-dependent IgE synthesis in PBMCs (26Fanslow W.C Anderson D.M Grabstein K.H Clark E.A Cosman D Armitage R.J. J. Immunol. 1992; 149: 655-660PubMed Google Scholar, 27Jabara H.H. Geha R.S. Int. Immunol. 1996; 8: 1503-1510Crossref PubMed Scopus (51) Google Scholar). Fig.2 shows that rsCD40-Ig, but not the control recombinant human soluble TNF receptor I immunoglobulin fusion protein (rsTNFR-Ig; R&D Systems), inhibits induction of IgE synthesis by sCD40L+IL-4 or rDiAg+IL-4. The enhancement of IgE synthesis observed with rsTNFR-Ig in the experiment presented was not reproducible, because it was not observed in other experiment. These results support the notion that induction of IgE isotype-switching by rDiAg+IL-4 is dependent on CD40. The immune responses of human cell lines to the addition of rDiAg remain to be elucidated. In this study, therefore, we first examined the response of rDiAg to a human cell line. THP-1 cells secreted IL-12 upon activation by rDiAg, rsCD40L (Bender Medsystems), or LPS, as shown in Fig. 3 a. Stimulation with 10 μg/ml rDiAg resulted in an up to 6-fold increase in secretion compared with that in non-treated controls. The addition of IL-10 to THP-1 cells stimulated with rDiAg rsCD40L, or LPS profoundly inhibited the production of IL-12. Phagocytosis of the cells was stimulated by addition of silica powder and hydroxyurea to the THP-1 cell culture medium, and TNF-α secretion was induced by rDiAg, rsCD40L, or LPS. As shown in Fig. 3 b, the addition of IL-10 to LPS-activated THP-1 cells stimulation profoundly inhibited the production of TNF-α. In contrast, when THP-1 cells were activated by rsCD40L or rDiAg, the production of TNF-α was not significantly affected by the addition of IL-10. To demonstrate a casual relationship between the DiAg-induced and CD40-induced productions of inflammatory cytokines in THP-1 cells, rsCD40-Ig fusion protein (25Hsu Y-M. Lucci J. Su L. Ehrenfels B. Garber E. Thomas D. J. Biol. Chem. 1997; 272: 911-915Abstract Full Text Full Text PDF PubMed Scopus (46) Google Scholar) was added to the cell culture (Fig.3 c). The addition of rsCD40-Ig to THP-1 cells activated by rDiAg and rsCD40L stimulation inhibited the production of IL-12. In contrast, when THP-1 cells were activated by LPS, the production of IL-12 was not affected by the addition of rsCD40-Ig. Following addition of rsTNFR-Ig into the cell culture as a negative control, none of the stimulations of activated THP-1 cells studied had any effect on IL-12 production (data not shown). To investigate the effects of direct binding of rDiAg to cell membrane molecules, binding assays with 125I-rDiAg were conducted on THP-1 cells expressing human CD40. 125I-rDiAg bound to the THP-1 cell membrane fractions in a concentration-dependent manner (Fig.4 a). 125I-rDiAg binding to membrane fractions revealed a large number of receptors (K d = 8.4 nm; 16,000 sites/cell) by Scatchard plot analysis (Fig. 4 b). Binding of125I-rDiAg to the THP-1 cell surface membrane was competitively inhibited by addition of rsCD40L and unlabeled rDiAg (Fig. 4 c). IC50 by rsCD40L and rDiAg were 3.6 × 10−8m and 2.4 × 10−7m, respectively. To confirm the ability of rDiAg to competitively inhibit 125I-rsCD40L binding to cell membrane molecules, binding assays with 125I-rsCD40L were conducted on Burkitt's lymphoma Ramos cells expressing human CD40 (28Ning Z.Q. Norton J.L. Li J. Murphy J.J. Eur. J. Immunol. 1996; 26: 2356-2363Crossref PubMed Scopus (35) Google Scholar). 125I-rsCD40L bound to the Ramos cell membrane fractions in a concentration-dependent manner (Fig.4 d). 125I-rsCD40L binding to membrane fractions revealed the possible existence of two types of receptors (K d high = 1.4 nm; 36,000 sites/cell and K d low = 30 nm; 1.8 × 105 sites/cell) by Scatchard plot analysis (Fig. 4 e). The high affinity of receptor was similar to the affinity of rDiAg binding. Binding of 125I-rsCD40L to the Ramos cell surface membrane was competitively inhibited by addition of unlabeled rsCD40L and rDiAg (Fig. 4 f). IC50 by rsCD40L and rDiAg were 3.3 × 10−8m and 3.8 × 10−7m, respectively. The data described above suggest that DiAg activated the immune system by binding to CD40. However, there is a possibility that 125I-rDiAg binds to molecules other than CD40 because CD40 is a member of the TNF-α receptor family (29van Kooten C. Banchereau J.J. Leukoc. Biol. 2000; 67: 2-17Crossref PubMed Scopus (1193) Google Scholar). We therefore attempted to determine whether or not rDiAg directly binds to rsCD40. The purified rDiAg and rsCD40L were immobilized on a 96-well plate and incubated with rsCD40-Ig and rsTNFR-Ig and then detected by incubating with anti-IgG Fc antibody. The specificity of binding was determined by competition with the excess of ligands added with the rsCD40. The purified rDiAg and rsCD40L were able to bind rsCD40-Ig in an immobilized ligand concentration-dependent manner (Fig.5 a), but rDiAg and rsCD40L were not able to bind rsTNFR-Ig (Fig. 5 b). To confirm whether the IgE-inductive and cell proliferation effects were due to CD40 agonist properties of DiAg, we compared the effects of DiAg in wild-type and CD40-deficient mice (30Kawabe T. Naka T. Yoshida K. Tanaka T. Fujiwara H. Suematsu S. Yoshida N. Kisimoto T. Kikutani H. Immunity. 1994; 1: 167-178Abstract Full Text PDF PubMed Scopus (985) Google Scholar) (Strain Name: B6.129P2-Tnfrsf5tm1Kik, Jackson Laboratory). The serum immunoglobulin levels of control and CD40-deficient mice are shown in Fig. 1. Basal serum levels of IgE in CD40-deficient mice were not significantly different from those in wild-type mice (Fig.1 a; day 0). CD40-deficient mice were infused with rDiAg or ovalbumin as a control. Total IgE production of wild-type mice was already significant at 14 days and was maximal at 21 days after administration of rDiAg (Fig. 1 a). On day 21 after administration, total and specific IgE production of ovalbumin was slightly increased, but DiAg-specific IgE production was not detected (Fig. 1 b). In contrast, total IgE production of CD40-deficient mice was completely absent. MLN-B cells were purified from CD40-deficient mice or wild-type mice to assess their ability to respond to stimulation of DiAgin vitro. As shown in Table I, MLN-B cells from CD40-deficient and wild-type mice exhibited comparable proliferative responses to LPS. MLN-B cells from wild-type mice stimulated with rDiAg showed enhanced proliferative responses. In contrast, MLN-B cells from CD40-deficient mice stimulated with rDiAg did not show such enhanced proliferation. It is known (30Kawabe T. Naka T. Yoshida K. Tanaka T. Fujiwara H. Suematsu S. Yoshida N. Kisimoto T. Kikutani H. Immunity. 1994; 1: 167-178Abstract Full Text PDF PubMed Scopus (985) Google Scholar) that B cells from CD40-deficient mice and wild-type mice exhibited commensurable proliferative responses to LPS, anti-IgM, and IL-4, although only CD40L did not respond to B cell from the CD40-deficient mice. This result resemble to our results of MLN-B cells responses by DiAg.Table ICD40-deficient mice MLN-B cell proliferative responsesStimulusWild-typeCD40-deficient%None100.0 (0.9)100.0 (1.0)rDiAg 3 μg/ml179.3 (2.4)95.1 (2.0)rDiAg 10 μg/ml251.7 (1.4)99.5 (1.4)LPS 10 μg/ml613.8 (2.6)175.1 (2.3)MLN-B cells were freshly prepared from small intestine of wild-type or CD40-deficient mice. Briefly, MLN cells were placed on 25-mm2tissue culture flasks at 37 °C for 1 h to deplete adherent cell fractions contaminating macrophages (repeat 3 times). Nonadherent cell fraction was treated with rabbit anti-mouse Thy-1.2 antibody (diluted 1:20; Cedalane Laboratories) at 4 °C for 1 h and subsequently with low tox rabbit complement (diluted 1:10; Cedalane Laboratories) at 37 °C for 1 h to deplete T cell fraction. MLN-B (1 × 106cells/ml) cells from CD40-deficient and wild-type mice were cultured for 3 days with either purified 3 or 10 μg/ml of rDiAg, 10 μg/ml of LPS, or no costimulus. Cell proliferation was measured by the MTT assay. The levels of proliferation represent the percentage of the OD value of the non-stimulus control. Data are shown as the mean % (± SE) of four samples from separate animals. Open table in a new tab MLN-B cells were freshly prepared from small intestine of wild-type or CD40-deficient mice. Briefly, MLN cells were placed on 25-mm2tissue culture flasks at 37 °C for 1 h to deplete adherent cell fractions contaminating macrophages (repeat 3 times). Nonadherent cell fraction was treated with rabbit anti-mouse Thy-1.2 antibody (diluted 1:20; Cedalane Laboratories) at 4 °C for 1 h and subsequently with low tox rabbit complement (diluted 1:10; Cedalane Laboratories) at 37 °C for 1 h to deplete T cell fraction. MLN-B (1 × 106cells/ml) cells from CD40-deficient and wild-type mice were cultured for 3 days with either purified 3 or 10 μg/ml of rDiAg, 10 μg/ml of LPS, or no costimulus. Cell proliferation was measured by the MTT assay. The levels of proliferation represent the percentage of the OD value of the non-stimulus control. Data are shown as the mean % (± SE) of four samples from separate animals. Dendritic cells are professional antigen-presenting cells that are specialized in the initiation of T cell-dependent immune responses. It is known that human dendritic cells (DC) secrete high levels of TNF-α and IL-12 upon either activation by lipopolysaccharide (LPS) or CD40 engagement (31Kato T. Yamane H. Nariuchi H. Cell. Immunol. 1997; 181: 59-67Crossref PubMed Scopus (50) Google Scholar). The addition of IL-10 during DC stimulation profoundly inhibited the production of the cytokines by LPS-activated DC (32Buelenes C. Verhasselt V. Groote D.D. Thielemans K. Goldman M. Willems F. Eur. J. Immunol. 1997; 27: 1848-1852Crossref PubMed Scopus (174) Google Scholar). In contrast, when DCs were activated by co-culture with CD40L transfectants, TNF-α were not significantly affected by the addition of IL-10, but IL-12 levels were markedly decreased (32Buelenes C. Verhasselt V. Groote D.D. Thielemans K. Goldman M. Willems F. Eur. J. Immunol. 1997; 27: 1848-1852Crossref PubMed Scopus (174) Google Scholar). It is also known that antigen-presenting THP-1 cell lines produce proinflammatory cytokines (23Yoshimoto T. Nagase H. Ishida T. Inoue J. Nariuchi H. Eur. J. Immunol. 1997; 27: 3461-3470Crossref PubMed Scopus (68) Google Scholar) such as IL-12 and TNF-α by CD40L stimulation. We found that rDiAg directly stimulated a human immune cell line, THP-1 cell, and induced proinflammatory cytokine production. When THP-1 cells were stimulated with rDiAg or recombinant human soluble CD40L (rsCD40L), IL-12 and TNF-α were induced. These results demonstrate that human antigen-presenting cells show similar responses to both CD40L and rDiAg. And the production of IL-12 was inhibited by addition of recombinant human soluble CD40 (rsCD40). rDiAg-induced cytokine production was not due to contamination of LPS in the preparation of recombinant protein for the following three reasons. First, the level of LPS within rDiAg, as revealed by Endotoxin Test-D (Seikagaku Co., Ltd., Tokyo, Japan), was below the detectable limit (sensitivity: 0.0058 enzyme units; 2 pg/ml ≤;). Second, C3H/HeJ mice, which are nonresponsive to LPS, responded to rDiAg as well as wild-type C3H/HeN mice (data not shown). Third, rDiAg activity was not affected by addition of polymixin B, an inhibitor of LPS (data not shown). rsCD40L competitively inhibited rDiAg binding to the membrane of these cells. 125I-rDiAg or 125I-rsCD40L bound to the cell membrane fraction, and this binding was competitively inhibited by addition of rsCD40L or rDiAg. Moreover, rDiAg bound directly to rsCD40. rDiAg was not affected in CD40-deficient mice. The experimental evidence (30Kawabe T. Naka T. Yoshida K. Tanaka T. Fujiwara H. Suematsu S. Yoshida N. Kisimoto T. Kikutani H. Immunity. 1994; 1: 167-178Abstract Full Text PDF PubMed Scopus (985) Google Scholar) with the CD40-deficient mice showed that the in vivo T cell-dependent immunoglobulin class switching but not the T cell-independent antibody responses is affected. Our results showed that polyclonal IgE induction by DiAg was affected in CD40-deficient mice. It means that DiAg induced polyclonal IgE by the mechanism that is not the T cell-independent antibody responses. If DiAg induces the class switching by the signals other than via CD40 molecules, DiAg induces polyclonal IgE production in CD40-deficient mice. Therefore, DiAg might induce the IgE class switching via the CD40 molecule with the IL-4. We concluded that DiAg is an agonist for human CD40. DiAg nonspecifically activates B cells through CD40 and secretes a large amount of polyclonal IgE antibodies. Antigen-nonspecific polyclonal IgE may be involved in the survival of the invading parasitic helminth. On the other hand, DiAg might interfere with the antigen-specific helper T cell activation by the CD40-CD40L binding. However, IL-4 is necessary for the IgE class switching and the differentiation into the Th2 cells, and the activation by DiAg are indispensable. DiAg might stimulate IL-4 production by Th2 cells in an as-yet-undefined manner. Armitage (22Armitage R.J. Tough T.W. Macduff B.M. Fanslow W.C. Spriggs M.K. Ramsdell F. Alderson M.R. Eur. J. Immunol. 1993; 23: 2326-2331Crossref PubMed Scopus (113) Google Scholar)et al. demonstrated that, in addition to its stimulatory effects on B cells and monocytes, CD40L costimulates the proliferation of activated T cells. This response is accompanied by the production of IFN-γ, TNF-α, and IL-2 but is largely IL-2 independent. These data demonstrated that CD40L is a T cell stimulatory factor, which may play an important role in interaction between T cells following activation through helminth infection. As an agonist of CD40, DiAg might be a T cell-stimulatory factor in the same manner as CD40L. In fact, low-level CD40 expression has previously been reported on some human T cell lines and gibbon T cell lymphomas (33Ware C.F. Crowe P.D. Vanarsdale T.L. Andrews J.L. Grayson M.H. Jrezy R. Smith C.A. Goodwin R.G. J. Immunol. 1991; 147: 4229-4238PubMed Google Scholar, 34Dunlap N.E. Berry A.K. Gore I. Decker W.D. Snyder T.L. Shaw G.M. Hanh B.H. Tildern A.B. Leukocyte Typing IV. Oxford University Press, Oxford, United Kingdom1989: 487-493Google Scholar, 35Indzhiia L.V. Yakoveleva L.A. Overbaugh L. Licciardi K.A. Chikobava M.G. Klotz I.N. Torres R. Indzhiia V.O. Lapin B.A. Clark E.A. Valentine M.A. J. Clin. Immunol. 1992; 12: 225-236Crossref PubMed Scopus (17) Google Scholar). During its several hundred million years of coexistence with a host, the helminth may have acquired the means to escape attack from the host immune system. To escape the host immune system, the parasitic helminth might have acquired the analogue of CD40L. As for the homologues of DiAg (36Spence H.J. Moore J. Brass A. Kennedy M.W. Mol. Biochem. Parasitol. 1993; 57: 339-344Crossref PubMed Scopus (40) Google Scholar, 37Britton C. Moore J. Gilleard J.S. Kennedy M.W. Mol. Biochem. Parasitol. 1995; 72: 77-88Crossref PubMed Scopus (34) Google Scholar, 38Ajuh P.M. Akue J.P. Boutin P. Everaere S. Egwang T.G. Exp. Parasitol. 1995; 81: 145-153Crossref PubMed Scopus (19) Google Scholar, 39Tweedie S. Paxton W.A. Ingram L. Maizels R.M. McReynolds L.A. Selkirk M.E. Exp. Parasitol. 1993; 76: 156-164Crossref PubMed Scopus (43) Google Scholar, 40Xia Y. Spence H.J. Moore J. Heaney N. Mcdermott L. Cooper A. Watson D.G. Mei B. Komuniecki R. Kennedy M.W. Parasitology. 2000; 120: 211-224Crossref PubMed Scopus (60) Google Scholar), the DNA and amino acid sequence is conserved in many families of helminth. These homologues are called polyproteins, which consist of repeating units including a cluster of tetra-basic amino acid sequences. The repeating units of all polyproteins might have agonistic effects for CD40. In fact, we found that a recombinant ABA-1 (Ascaris lumbricoides polyprotein) has similar biological activity to rDiAg (data not shown). The preservation of a similar protein by numerous species might indicate that the protein plays an important role. It has been reported that ABA-1 has other biological activities, including binding to small lipids (40Xia Y. Spence H.J. Moore J. Heaney N. Mcdermott L. Cooper A. Watson D.G. Mei B. Komuniecki R. Kennedy M.W. Parasitology. 2000; 120: 211-224Crossref PubMed Scopus (60) Google Scholar). It is not known whether the binding to the lipid induces the production of IgE in B cells, or whether it induces the cytokine production in monocyte cell lines. The maximum K d value of binding to the lipid of recombinant ABA-1 is about 1 mm, and its binding affinity is low. Such binding power is not sufficient to explain the specific biological activity on the part of this polyprotein. The binding of rDiAg to CD40 occurs with relatively high affinity and could explain the specificity of the immune responses by rDiAg. The homology between the amino acid sequences of DiAg and sCD40L is not high. In the isoelectric point forecast from the amino acid sequence, rDiAg was 8.5 and rsCD40L was 9.5. There was little similarity in the presumable secondary structure between the two peptides (data not shown). It has been reported that the soluble recombinant form of CD40L has a trimeric structure (21Mazzei G.J. Edgerton M.D. Losberger C. Lecoanet-Henchoz S. Garber P. Durandy A. Gauchat J-F. Bernard A. Allet B. Bonnefoy J-Y. J. Biol. Chem. 1995; 270: 7025-7028Abstract Full Text Full Text PDF PubMed Scopus (154) Google Scholar) and that the three-dimensional structure of rDiAg might be similar to the trimeric structure of sCD40L. It is known that the anti-CD40 antibody often shows agonistic activity. Such foreign proteins as anti-CD40 antibodies and rDiAg might show agonistic activity, since the ligand recognition of the CD40 molecule is a little vague. The similarity of the responses of DiAg between humans and rodents shows that specificity in the interspecies of CD40 is low. It is not unusual for numerous species to share in common a molecule that serves a similar function. We hypothesize that DiAg is a molecule newly acquired to maintain the species by the process of evolution within the special environment of parasitism. The potential role of the CD40/CD40L engagement is very important, and many immunologists have been engaged in the study of this molecule in recent years. The helminth can be said to have recognized the importance of this molecule for several hundred million years. And indeed, it is quite a feat to have acquired such a molecule for the purpose of evading the host immune system. The parasitic helminth may have acquired the ability to escape the host immune system through evolutionary acquisition of CD40 agonist. We thank Dr. M. Owhashi (University of Tokushima) for discussions and for providing the DiNCF cDNA used in this study." @default.
• W2015954787 created "2016-06-24" @default.
• W2015954787 creator A5017551637 @default.
• W2015954787 creator A5031078248 @default.
• W2015954787 creator A5035844876 @default.
• W2015954787 creator A5063210787 @default.
• W2015954787 creator A5081413351 @default.
• W2015954787 date "2001-12-01" @default.
• W2015954787 modified "2023-09-29" @default.
• W2015954787 title "A Factor of Inducing IgE from a Filarial Parasite Is an Agonist of Human CD40" @default.
• W2015954787 cites W1517873264 @default.
• W2015954787 cites W1581150959 @default.
• W2015954787 cites W1592901497 @default.
• W2015954787 cites W1756135215 @default.
• W2015954787 cites W1969431824 @default.
• W2015954787 cites W1975538194 @default.
• W2015954787 cites W1980625714 @default.
• W2015954787 cites W1981956333 @default.
• W2015954787 cites W1987968095 @default.
• W2015954787 cites W1999239244 @default.
• W2015954787 cites W2002071039 @default.
• W2015954787 cites W2007824525 @default.
• W2015954787 cites W2012037623 @default.
• W2015954787 cites W2016353500 @default.
• W2015954787 cites W2023421909 @default.
• W2015954787 cites W2028724191 @default.
• W2015954787 cites W2029249439 @default.
• W2015954787 cites W2031074431 @default.
• W2015954787 cites W2039787192 @default.
• W2015954787 cites W2049410931 @default.
• W2015954787 cites W2060382742 @default.
• W2015954787 cites W2067492735 @default.
• W2015954787 cites W2067517886 @default.
• W2015954787 cites W2067640954 @default.
• W2015954787 cites W2069942730 @default.
• W2015954787 cites W2076376284 @default.
• W2015954787 cites W2084318119 @default.
• W2015954787 cites W2087973624 @default.
• W2015954787 cites W2090878038 @default.
• W2015954787 cites W2093888807 @default.
• W2015954787 cites W2101492664 @default.
• W2015954787 cites W2111668089 @default.
• W2015954787 cites W2133128339 @default.
• W2015954787 cites W2137268127 @default.
• W2015954787 cites W2141738471 @default.
• W2015954787 cites W2162320664 @default.
• W2015954787 cites W2332041332 @default.
• W2015954787 doi "https://doi.org/10.1074/jbc.m104581200" @default.
• W2015954787 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11591702" @default.
• W2015954787 hasPublicationYear "2001" @default.
• W2015954787 type Work @default.
• W2015954787 sameAs 2015954787 @default.
• W2015954787 citedByCount "19" @default.
• W2015954787 countsByYear W20159547872012 @default.
• W2015954787 countsByYear W20159547872013 @default.
• W2015954787 countsByYear W20159547872018 @default.
• W2015954787 countsByYear W20159547872021 @default.
• W2015954787 crossrefType "journal-article" @default.
• W2015954787 hasAuthorship W2015954787A5017551637 @default.
• W2015954787 hasAuthorship W2015954787A5031078248 @default.
• W2015954787 hasAuthorship W2015954787A5035844876 @default.
• W2015954787 hasAuthorship W2015954787A5063210787 @default.
• W2015954787 hasAuthorship W2015954787A5081413351 @default.
• W2015954787 hasBestOaLocation W20159547871 @default.
• W2015954787 hasConcept C136764020 @default.
• W2015954787 hasConcept C141105273 @default.
• W2015954787 hasConcept C159654299 @default.
• W2015954787 hasConcept C170493617 @default.
• W2015954787 hasConcept C185592680 @default.
• W2015954787 hasConcept C203014093 @default.
• W2015954787 hasConcept C2778938600 @default.
• W2015954787 hasConcept C41008148 @default.
• W2015954787 hasConcept C55493867 @default.
• W2015954787 hasConcept C71928629 @default.
• W2015954787 hasConcept C86803240 @default.
• W2015954787 hasConceptScore W2015954787C136764020 @default.
• W2015954787 hasConceptScore W2015954787C141105273 @default.
• W2015954787 hasConceptScore W2015954787C159654299 @default.
• W2015954787 hasConceptScore W2015954787C170493617 @default.
• W2015954787 hasConceptScore W2015954787C185592680 @default.
• W2015954787 hasConceptScore W2015954787C203014093 @default.
• W2015954787 hasConceptScore W2015954787C2778938600 @default.
• W2015954787 hasConceptScore W2015954787C41008148 @default.
• W2015954787 hasConceptScore W2015954787C55493867 @default.
• W2015954787 hasConceptScore W2015954787C71928629 @default.
• W2015954787 hasConceptScore W2015954787C86803240 @default.
• W2015954787 hasIssue "49" @default.
• W2015954787 hasLocation W20159547871 @default.
• W2015954787 hasOpenAccess W2015954787 @default.
• W2015954787 hasPrimaryLocation W20159547871 @default.
• W2015954787 hasRelatedWork W198326150 @default.
• W2015954787 hasRelatedWork W1993757192 @default.
• W2015954787 hasRelatedWork W1995347403 @default.
• W2015954787 hasRelatedWork W2024105453 @default.
• W2015954787 hasRelatedWork W2087982072 @default.
• W2015954787 hasRelatedWork W2109291059 @default.
• W2015954787 hasRelatedWork W2129443427 @default.
• W2015954787 hasRelatedWork W2147388743 @default.

• next